| Ytd | -52.91% | |
| 1y | -83.63% |
| Open | 0.95 | Prev Close | 0.99 | Low | 0.92 | High | 0.98 | Mkt Cap | 3.36M |
| Vol | 31.54K | Avg Vol | 87.45K | EPS | -2.67 | P/E | N/A | Forward P/E | -0.65 |
| Beta | 2.54 | Short Ratio | 0.34 | Inst. Own | 1.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.20 | 200-d Avg | 2.07 | 1yr Est | 3.40 |
SXTP News
Innoviva (NASDAQ: INVA - Get Free Report) and 60 Degrees Pharmaceuticals (NASDAQ: SXTP - Get Free Re
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001946563/000121390026099702/ea0305442-8k_60degree.
Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's aft
60 Degrees Pharma (Nasdaq: SXTP) will present on demand at H.C. Wainwright beginning Sept. 11 and ho
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market
Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's aft
60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(0.90) per share which missed the analyst con
WASHINGTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW)
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday'
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP, SXTPW))) ("60 Degrees" or the "Company
WASHINGTON, July 30, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP, SXTPW)
Company plans to request an FDA meeting following the interim readout to discuss the regulatory path
https://x.com/PatentGrants/status/2081831140466569485 https://patentcenter.uspto.gov/applications/18
License expands collaboration with Florida State University to evaluate castanospermine for Powassan
60 Degrees Pharma (Nasdaq: SXTP) secures exclusive option to develop castanospermine for tick-borne
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP, SXTPW))) ("60 Degrees Pharma" or the "Com
WASHINGTON, July 01, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW
License allows the Company to commence large-scale extraction of castanospermine from the seeds of C
License allows the Company to commence large-scale extraction of castanospermine from the seeds of
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001946563/000121390026064796/ea0293532-8k_60degrees
Enrollment is tracking ahead of schedule, allowing potential acceleration of key trial milestones Mi
Ascendiant Capital analyst Lucas Ward maintains 60 Degrees (NASDAQ:SXTP) with a Buy and lowers th
60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(1.28) per share which missed the analyst con
WASHINGTON, May 15, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP ; SXTP
60 Degrees Pharmaceuticals Inc. (NASDAQ: SXTP - Get Free Report) was the target of a significant dec
60 Degrees Pharmaceuticals Inc. (SXTP) might move higher on growing optimism about its earnings pros
FY 2025 net product revenues increased 65% to $1,005,000 Current shelf capacity exhausted after rais
60 Degrees files NDIN with FDA for Australian Chestnut Extract; May 25 decision deadline. FSU capsul
60 Degrees Pharmaceuticals Inc. (NASDAQ: SXTP) shares are down during Friday's premarket session. Th
All three patients in 60 Degrees Pharma's expanded access study were cured of relapsing babesiosis a
Rafael (NYSE: RFL - Get Free Report) and 60 Degrees Pharmaceuticals (NASDAQ: SXTP - Get Free Report)
GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine)Collaboration designed t
GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine) Collaboration designed
60 Degrees Pharmaceuticals Inc. (NASDAQ: SXTP) shares are set to reverse split on the morning of Tue